VEGFA and triple-negative breast carcinoma: Moreover, research indicates miR-5195-3p’s ability to restrain growth and boost chemosensitivity in triple-negative breast cancer [34], as well as its role in curbing proliferation and EMT, and enhancing apoptosis in NSCLC by focusing on VEGFA [26].